(Q35825857)

English

Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man

scientific article published in November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

M R Downham

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

T R Auton

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A Rosul

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

H L Sharp

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

L Sjöström

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A Rushton

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

J P Richards

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

T G K Mant

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

S M Gardiner

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

T Bennett

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

J F Glover

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

56

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

505-512

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

The next generation of vaccines for the treatment of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Keyhole limpet hemocyanin (KLH): a biomedical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Preparation and properties of totally synthetic immunogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

The role of structure in antibody cross-reactivity between peptides and folded proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Angiotensin II receptor inhibition. A new therapeutic principle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Immunological and formulation design considerations for subunit vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Carrier-priming leads to hapten-specific suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Antibodies That React with Predetermined Sites on Proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Tapping the immunological repertoire to produce antibodies of predetermined specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Immunologic reduction of bladder cancer recurrence rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Antibodies to Small Molecules: Biological and Clinical Applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Immunologic approaches to blockade of the renin-angiotensin system: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Effect of priming with carrier on response to conjugate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Carrier-induced epitopic suppression, a major issue for future synthetic vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Distinctive development of IgG4 subclass antibodies in the primary and secondary responses to keyhole limpet haemocyanin in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Clinical Pharmacodynamic Studies with Cilazapril and a Combination of Cilazapril and Propranolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

11 July 2018

Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01926.X

21 January 2018

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884403

24 September 2018

Non-angiotensin effects of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01926.X

21 January 2018

Keyhole limpet hemocyanin: structural and functional characterization of two different subunits and multimers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01926.X

21 January 2018

Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carrier-induced epitopic suppression is initiated through clonal dominance

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carrier-induced suppression of the antibody response to a 'self' hapten

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Product development plan for new vaccine technologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic response of atopic and normal individuals to keyhole limpet hemocyanin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical and immunogenic properties of a purified keyhold limpet haemocyanin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human secondary immune response to Keyhole limpet haemocyanin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthetic peptides as the basis for future vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14651724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2003.01926.X

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35825857&oldid=2098751970"